Cialis Prolonged Activity Widens Nitrate Concern; Risk Management Requested

Cialis’ distinguishing feature – its longer window for efficacy than competing erectile dysfunction agents – also triggered concerns about a longer window for safety problems with the Lilly/Icos drug, FDA review documents indicate.

More from Archive

More from Pink Sheet